Ace NURS 3100 Exam 1 in 2025 – Your Ultimate Nursing Adventure Starts Here!

By choosing option A, the student nurse demonstrates an understanding of how the FDA has decreased the amount of time involved in bringing a new drug to the market. When drug manufacturers are required by the FDA to test more drugs on an annual basis, it can lead to a more streamlined approval process because it encourages manufacturers to conduct more efficient and rigorous testing upfront. This can help to identify potential issues earlier in the drug development process, ultimately reducing delays in approval and bringing new drugs to market faster.

Options B, C, and D are incorrect:

Option B suggests that drug manufacturers paying yearly user fees allow the FDA to hire more employees, but this does not directly address how the FDA decreases the time involved in bringing a new drug to market.

Option C implies that consumer demand has led to a streamlined process, which is not a direct factor in the FDA's efforts to reduce approval time.

Option D, stating the FDA is less strict with drug approval, does not indicate an understanding of the FDA's process for decreasing approval time.